Cordycepin buffers anisomycin-induced fear memory deficit by restoring hippocampal BDNF

Biochem Biophys Res Commun. 2023 Jul 12:665:118-123. doi: 10.1016/j.bbrc.2023.05.011. Epub 2023 May 3.

Abstract

The process of memory consolidation involves the synthesis of new proteins, and interfering with protein synthesis through anisomycin can impair memory. Memory deficits due to aging and sleep disorders may also result from a reduction in protein synthesis. Rescuing memory deficits caused by protein synthesis deficiency is therefore an important issue that needs to be addressed. Our study focused on the effects of cordycepin on fear memory deficits induced by anisomycin using contextual fear conditioning. We observed that cordycepin was able to attenuate these deficits and restore BDNF levels in the hippocampus. The behavioral effects of cordycepin were dependent on the BDNF/TrkB pathway, as demonstrated by the use of ANA-12. Cordycepin had no significant impact on locomotor activity, anxiety or fear memory. Our findings provide the first evidence that cordycepin can prevent anisomycin-induced memory deficits by regulating BDNF expression in the hippocampus.

Keywords: Anisomycin; Brain-derived neurotrophic factor (BDNF); Contextual fear conditioning; Cordycepin; Fear memory; Hippocampus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anisomycin / pharmacology
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Fear* / physiology
  • Hippocampus / metabolism
  • Humans
  • Memory Disorders / chemically induced
  • Memory Disorders / drug therapy
  • Memory Disorders / metabolism

Substances

  • Anisomycin
  • Brain-Derived Neurotrophic Factor
  • cordycepin